<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2018.84010</article-id><article-id pub-id-type="publisher-id">OJNeph-88437</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Acute Kidney Injury during Malaria in Togolese Children
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kossi</surname><given-names>Akomola Sabi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Befa</surname><given-names>Noto Kadou Kaza</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eyram</surname><given-names>Yoan Makafui Amekoudi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weu</surname><given-names>Melanie Tia</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jacques</surname><given-names>Vigan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamat</surname><given-names>Ibrahim</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guillaume</surname><given-names>Abderhamman Mahamat</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sandra</surname><given-names>Amouzou-Glikpa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edem</surname><given-names>Djadou</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Clinique de néphrologie, CNHU, Cotonou. Bénin</addr-line></aff><aff id="aff2"><addr-line>Service de néphrologie et d’hémodialyse, CHU de YOPOUGON, Abidjan, République de C&amp;amp;ocirc;te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Service de néphrologie et hémodialyse, CHU SylvanusOlympio, Lomé, Togo</addr-line></aff><aff id="aff4"><addr-line>Service de néphrologie et d’hémodialyse, h&amp;amp;ocirc;pital universitaire de N’djaména, Tchad</addr-line></aff><aff id="aff5"><addr-line>Service de pédiatrie, CHU SylvanusOlympio, Lomé, Togo</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>11</month><year>2018</year></pub-date><volume>08</volume><issue>04</issue><fpage>85</fpage><lpage>93</lpage><history><date date-type="received"><day>5,</day>	<month>August</month>	<year>2018</year></date><date date-type="rev-recd"><day>10,</day>	<month>November</month>	<year>2018</year>	</date><date date-type="accepted"><day>13,</day>	<month>November</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <u><b>Objective:</b></u> To describe clinical, biological and evolutionary profile of Acute Kidney Injury (AKI) due to Severe Malaria in the pediatric department. 
  <u><b>Methodology:</b></u> This was a retrospective descriptive study that took place from January to December 2012. It has been included children aged 0 - 15 years admitted for severe malaria with positive thick drop. AKI was defined by using the modified RIFLE (Risk Injury Failure Loss End stage) classification for Pediatrics. 
  <u><b>Results:</b></u> 338 children admitted for severe malaria were included. AKI was diagnosed in 24 children, a prevalence of 7.1% according to pRIFLE classification: RISK in 10 (3%), INJURY in 9 (2.6%) and FAILURE in 5 (1.5%). The average age was 8.16 &#177; 4.2 years. Clinical features were dominated by hemoglobinuria in 87.5%, oliguria, vomiting and fever in 75%. The biological features were dominated by severe anemia (Hb &lt; 6 g/dl) in 79.2% of cases. Hyperkalemia (K &gt; 5.5 mmol/l) was found in 2 cases. The mean parasitic density was 22,120 trophozoites. Malaria was treated primarily with artemether in 83.3% of the cases. Dialysis was indicated in 2 cases for menacing hyperkalaemia, but was not done because of lack of financial means. In one case, hyperkalaemia was successfully treated with symptomatic measures, but in the second case, these measures were not allowed to normalize kalaemia, and death occurred. 
  <u><b>Conclusion:</b></u> Acute post-malarial renal failure secondary to tubular necrosis may be the dominant clinical features of severe malaria. Death may occur. Preventing malaria would be the best way to avoid it.
 
</p></abstract><kwd-group><kwd>AKI</kwd><kwd> Severe Malaria</kwd><kwd> Haemoglobinuria</kwd><kwd> Togo</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Malaria, the first parasitic endemic in the world, still remains a major public health problem, with sub-Saharan Africa accounting for 80% of the 300 millions of malaria cases reported in the world in 2012 [<xref ref-type="bibr" rid="scirp.88437-ref1">1</xref>] . According to World Health Organization (WHO) global estimations in 2012, 1,000,000 deaths occurred and majority of them among children were less than five years old [<xref ref-type="bibr" rid="scirp.88437-ref1">1</xref>] . Acute kidney injury (AKI) is a common complication of severe malaria (SM) in adults, affecting up to 40% of patients [<xref ref-type="bibr" rid="scirp.88437-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref2">2</xref>] . In the absence of appropriate renal replacement therapy (RRT), the case fatality rate approaches 75% [<xref ref-type="bibr" rid="scirp.88437-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref2">2</xref>] . Clinically and pathologically, AKI in adults with SM resembles acute tubular necrosis [<xref ref-type="bibr" rid="scirp.88437-ref3">3</xref>] . In the world, there are limited data on the incidence of AKI in pediatric SM with estimates ranging from 3% to 31% [<xref ref-type="bibr" rid="scirp.88437-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] . In Africa, the few existing data estimates AKI in pediatric SM between 23% and 45% [<xref ref-type="bibr" rid="scirp.88437-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] . In Togo, there are only two old epidemiological studies which concerned severe pediatric malaria in general [<xref ref-type="bibr" rid="scirp.88437-ref8">8</xref>] . Our study, the first of its kind in Togo, aims to describe clinical, biological and evolutionary profile of AKI due to SM in the pediatric department of Sylvanus Olympio Teaching Hospital of Lome.</p></sec><sec id="s2"><title>2. Methodology</title><p>This was a retrospective descriptive study that took place from January to December 2012 in the pediatric department of Sylvanus Olympio Teaching Hospital of Lome. Have been included children aged 0 - 15 years admitted for severe malaria with positive thick drop. Included were all records of both sexes, aged 0 - 15 years, admitted for severe malaria with associated or not to signs of kidney damage such as oliguria, anuria, haematuria, hemoglobinuria, facial edema, or edema of the lower limbs. Not included in our study children admitted for severe malaria with a thick negative drop, those admitted in pediatric with positive thick drop without renal failure. Data concerned sociodemographic, clinical, biological, therapeutic and evolutionary were collected. AKI was defined by using the modified RIFLE (Risk Injury Failure Loss End stage) classification for Pediatrics (pRIFLE): estimated creatinine clearance (calculated according to Schwartz formula) decreased by at least 25%, or diuresis &lt; 0.5 ml/kg/h for 8 hours [<xref ref-type="bibr" rid="scirp.88437-ref9">9</xref>] . When the Creatinine is unknown, the decline in the estimated GFR (Glomerular Filtration R ate) was calculated from of a reference value of 100 ml/min/1.73 m<sup>2</sup> (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Statistical software</p><p>The Statistical software SPSS 18.0 was used for the analysis of the data. Student t test (two tailed, independent) has been used to find the significance of</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> pRIFLE classification of AKI</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Estimated CrCl</th><th align="center" valign="middle" >Urine output</th></tr></thead><tr><td align="center" valign="middle" >Risk</td><td align="center" valign="middle" >eCrCl decrease by 25%</td><td align="center" valign="middle" >&lt;0.5 ml/kg/h for 8 h</td></tr><tr><td align="center" valign="middle" >Injury</td><td align="center" valign="middle" >eCrC decrease by 50%</td><td align="center" valign="middle" >&lt;0.5 ml/kg/h for 16 h</td></tr><tr><td align="center" valign="middle" >Failure</td><td align="center" valign="middle" >eCrC decrease by 75% or eCrCl &lt; 35 ml/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" >&lt;0.3 ml/kg/h for 24 h or anuric for 12 h</td></tr><tr><td align="center" valign="middle" >Loss</td><td align="center" valign="middle" >Persistent failure &gt; 4 weeks</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >End stage</td><td align="center" valign="middle" >End-stage renal disease (persistent failure &gt; 3 months)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>eCrCl, estimated creatinine clearance; pRIFLE, pediatric risk, injury, failure, loss and end-stage renal disease.</p><p>study parameters on continuous scale between two groups (Inter group analysis) on metric parameters. Chi square/Fisher Exact test has been used to find the significance of study parameters on categorical scale between two or more groups.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period 338 children admitted for severe malaria were included. AKI was diagnosed in 24 children, a prevalence of 7.1% according to pRIFLE classification: RISK in 10 (3%), INJURY in 9 (2.6%) and FAILURE in 5 (1.5%) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>The sex ratio was 2.43 with an average age of 8.16 &#177; 4.2 years (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>The rate of self-medication recovered is high (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>At admission, clinical features were dominated by hemoglobinuria in 87.5%, oliguria, vomiting and fever in 75%. Hypotension was found in 37.5% of the cases (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>The biological features were dominated by severe anemia (Hb &lt; 6 g/dl) in 79.2% of cases. Hyperkalemia (K &gt; 5.5 mmol/l) was found in 2 cases with a context of anuria in one case (<xref ref-type="table" rid="table4">Table 4</xref>). All the thick drops were positive to Plasmodium Falciparum. The mean parasitic density was 22,120 trophozoites with extremes of 190 and 98,810 parasites/mm<sup>3</sup>. For treatment, 25% of patients received quinine treatment before admission. During hospitalization, 58.3% of children needed blood transfusion. Malaria was treated primarily with artemether in 83.3% of the cases (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>Dialysis was indicated in 2 cases for menacing hyperkalaemia, but was not done because of lack of financial means. In one case, hyperkalaemia was succefully treated with symptomatic measures (insulin in glucose serum, furosemide, bicarbonate serum). In the second case, these measures not allowed to normalize kalaemia because of anuria, and finally death occurred. In all other cases, renal function was recovered in 91.6%. Only one child had kidney function below 30 ml/min/1.73 m<sup>2</sup> after 3 weeks. H was referred to nephrologist for follow-up (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Malaria was treated effectively in all cases attested by a negative thick dropscontrol after an average stay of 16 &#177; 4.4 days.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Prevalence of AKI stratified by the pRIFLE definition</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >pRIFLE</th><th align="center" valign="middle" >Prevalence</th><th align="center" valign="middle" >Average of eCrCl</th></tr></thead><tr><td align="center" valign="middle" >No AKI</td><td align="center" valign="middle" >314 (92.9%)</td><td align="center" valign="middle" >104 ml/min/1.73 m<sup>2</sup></td></tr><tr><td align="center" valign="middle" >Risk</td><td align="center" valign="middle" >10 (3%)</td><td align="center" valign="middle" >58 ml/min/1.73 m<sup>2</sup></td></tr><tr><td align="center" valign="middle" >Injury</td><td align="center" valign="middle" >3 (2.6%)</td><td align="center" valign="middle" >38.7 ml/min/1.73 m<sup>2</sup></td></tr><tr><td align="center" valign="middle" >Failure</td><td align="center" valign="middle" >5 (1.5%)</td><td align="center" valign="middle" >17.4 ml/min/1.73 m<sup>2</sup></td></tr></tbody></table></table-wrap><p>eCrCl, estimated creatinine clearance; pRIFLE, pediatric risk, injury, failure, loss and end-stage renal disease.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Antecedents distribution</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Antecedent</th><th align="center" valign="middle" >N = 24</th></tr></thead><tr><td align="center" valign="middle" >HTA</td><td align="center" valign="middle" >0 (0%)</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >0 (0%)</td></tr><tr><td align="center" valign="middle" >Allergie to quinine</td><td align="center" valign="middle" >1 (4.2%)</td></tr><tr><td align="center" valign="middle" >Self-medication</td><td align="center" valign="middle" >14 (58.3%)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >9 (37.5%)</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution according pattern, clinical and biological data of admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Pattern/Data</th><th align="center" valign="middle" >N = 24</th></tr></thead><tr><td align="center" valign="middle" >Extra renal origin</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Fever &gt; 38˚C</td><td align="center" valign="middle" >18 (75%)</td></tr><tr><td align="center" valign="middle" >Hypotension</td><td align="center" valign="middle" >9 (37.5%)</td></tr><tr><td align="center" valign="middle" >Prostration</td><td align="center" valign="middle" >9 (37.5%)</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >18 (75%)</td></tr><tr><td align="center" valign="middle" >Convulsion</td><td align="center" valign="middle" >10 (41.6%)</td></tr><tr><td align="center" valign="middle" >Icteria</td><td align="center" valign="middle" >10 (41.6%)</td></tr><tr><td align="center" valign="middle" >Renal origin</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oliguria (&lt;12 ml/kg/24 h)</td><td align="center" valign="middle" >18 (75%)</td></tr><tr><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >3 (12.5%)</td></tr><tr><td align="center" valign="middle" >Hemoglobinuria</td><td align="center" valign="middle" >21 (87.5%)</td></tr><tr><td align="center" valign="middle" >Biology data</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Anemia (&lt;6 g/dl)</td><td align="center" valign="middle" >19 (79.2%)</td></tr><tr><td align="center" valign="middle" >Thrombopenia (&lt;150,000/mm<sup>3</sup>)</td><td align="center" valign="middle" >18 (75%)</td></tr><tr><td align="center" valign="middle" >Hyperleukocytosis (&gt;10,000/mm<sup>3</sup>)</td><td align="center" valign="middle" >10 (41.6%)</td></tr><tr><td align="center" valign="middle" >Hyperbilirubinemia (&gt;2 mg/l)</td><td align="center" valign="middle" >9 (37.5%)</td></tr><tr><td align="center" valign="middle" >ASAT (≥1.5 N)</td><td align="center" valign="middle" >21 (87.5%)</td></tr><tr><td align="center" valign="middle" >ALAT (≥1.5 N)</td><td align="center" valign="middle" >9 (37.5%)</td></tr><tr><td align="center" valign="middle" >Hyponatremia (&lt;135 mmol/l)</td><td align="center" valign="middle" >3 (12.5%)</td></tr><tr><td align="center" valign="middle" >Hyperkaliemia (&gt;5.5 mmol/l)</td><td align="center" valign="middle" >2 (8.3%)</td></tr><tr><td align="center" valign="middle" >Urea (≥1 mmol/l)</td><td align="center" valign="middle" >2 (8.3%)</td></tr></tbody></table></table-wrap><p>ASAT: aspartate aminotransferase; ALAT: Alanine aminotransferase.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Treatment received before and during hospitalization</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of treatement</th><th align="center" valign="middle" >N = 24</th></tr></thead><tr><td align="center" valign="middle" >Before hospitalization</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Quinine</td><td align="center" valign="middle" >6 (25%)</td></tr><tr><td align="center" valign="middle" >Artemether</td><td align="center" valign="middle" >2 (8.33%)</td></tr><tr><td align="center" valign="middle" >Analgesics</td><td align="center" valign="middle" >5 (20.83%)</td></tr><tr><td align="center" valign="middle" >Anticonvulsivants</td><td align="center" valign="middle" >2 (8.33%)</td></tr><tr><td align="center" valign="middle" >Traditionnal</td><td align="center" valign="middle" >1 (4.17%)</td></tr><tr><td align="center" valign="middle" >During hospitalization</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Transfusion</td><td align="center" valign="middle" >14 (58.33%)</td></tr><tr><td align="center" valign="middle" >Diuretic</td><td align="center" valign="middle" >4 (16.67%)</td></tr><tr><td align="center" valign="middle" >Antimalarial</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Artemether</td><td align="center" valign="middle" >20 (83.33%)</td></tr><tr><td align="center" valign="middle" >Quinine</td><td align="center" valign="middle" >4 (16.66%)</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>In endemic areas of Malaria, AKI is a common complication, but there are limited data on the incidence of AKI in pediatric SM with estimates ranging from 3% to 31% [<xref ref-type="bibr" rid="scirp.88437-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref10">10</xref>] . In Togo, our study is the first which talk about this item. The prevalence of AKI due to severe malaria is 7.1% in our study, lower than the 23.6% found in the Congo [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] or the 30.4% found in India [<xref ref-type="bibr" rid="scirp.88437-ref11">11</xref>] . This difference would probably be related to the retrospective nature of our study. Our prevalence is nevertheless more important than that of several works of the 2000s [<xref ref-type="bibr" rid="scirp.88437-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref13">13</xref>] , suggesting that the association of AKI with malaria would be a new factor. This hypothesis is supported in several studies which prove the resurgence in endemic area of bilious fever hemoglobinuria which was considered in the years 1950-1970 erroneously as only the disease of nonimmune subjects to malaria [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref16">16</xref>] . The average age of our patients was 8 years, similar to that reported in the study by Bodi et al. [<xref ref-type="bibr" rid="scirp.88437-ref15">15</xref>] . AKI is predominant in our study by the early stages of the RIFLE classification (R and I stages: 19 of 24 patients, 79.2%), which shows a large part of functional renal failure in pathophysiology of AKI during malaria. Moreover, hypotension was present in 37% of cases, vomiting in 75% and severe anemia in 79%. In the literature, hemoglobinuria, which prevalence remains high in studies [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref15">15</xref>] , including our study (87%), is the main pathogenesis of acute renal failure during malaria. This hemoglobinuria resulting from intravascular haemolysis is not the only mechanism of AKI due to malaria. It resulting from many factors such as: cytoadherence and erythrocyte sequestration with intravascular coagulation, responsible for hypo-perfusion; dehydration and hypovolemia related to fever, profuse sweating, lack of water supply and digestive disorder, also leading to renal hypo-perfusion; Activation of monocytes with release of cytokines, free radicals and immunoglobulins. These phenomena contribute to the establishment of acute tubular necrosis in malaria [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] . In our study, nearly one quartz of patients had been treated with quinine (25%) and analgesic (20%), which could be another factor of AKI. The hemolyzing effect of quinine is known in particular hemoglobinopathies [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref18">18</xref>] . The majority of our patients have been treated with artemether with total effectiveness. However, 2 patients presented hyperkalaemia requiring emergency dialysis, but not realized due to lack of financial means leading to the death of one patient. The problem of lack of care in emergency dialysis is recurring in Togo where until now there is only one hemodialysis center for the whole country [<xref ref-type="bibr" rid="scirp.88437-ref19">19</xref>] . Patients pay for their hemodialysis sessions themselves. There is only one adult nephrologist per 7 million inhabitants [<xref ref-type="bibr" rid="scirp.88437-ref19">19</xref>] . Peritoneal dialysis, normally adapted to children, is not available. The mortality in our study is 4.16%, different from the results of Ivoiry Coast, Nigeria and Congo where it is above 10% [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.88437-ref20">20</xref>] . The average hospital stay is 16 + 4.4 days, similar to the results of Kunuanunua [<xref ref-type="bibr" rid="scirp.88437-ref7">7</xref>] . Classic duration of acute tubular necrosis evolution is the explanation. Of the 24 patients collected, 95% fully recovered renal function. A single patient who has not fully recovered will gradually progress to chronic renal failure and will be an additional burden on the already dying health system. The weakness of study is it’s retrospective nature. Obviously the size of our sample does not allow us to make relevant statistical tests.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Acute renal failure often secondary to tubular necrosis may be the dominant clinical feature of severe malaria. Death may occur; its prognosis depends on early diagnosis and the prompt introduction of adequate treatment. As always, malaria prevention would be the best way to avoid it. In Togo the setting up of a structure adapted to the management of acute kidney failure in general and especially adapted to pediatrics will improve the prognosis of this pathology of which our study shows only the part emerged from the iceberg because of its retrospective and monocentric character.</p></sec><sec id="s6"><title>Availability of Data and Materials Section</title><p>All data generated or analyzed during this study are included in this published article.</p></sec><sec id="s7"><title>Acknowledgements</title><p>No particular acknowledgment.</p></sec><sec id="s8"><title>Ethics and Consent Statement</title><p>Not applicable.</p></sec><sec id="s9"><title>Funding</title><p>No funding was received.</p></sec><sec id="s10"><title>Author’s Contribution</title><p>All authors have contributed to a published study to conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content and have given final approval of the version to be published.</p></sec><sec id="s11"><title>What Is Already Known about This Topic?</title><p>In the world, there are limited data on the incidence of Acute Kidney Injury (AKI) in pediatric Severe Malaria (SM). In Africa, the existing data is very limited.</p></sec><sec id="s12"><title>What This Study Adds?</title><p>Our study, the first of its kind in Togo, aims to describe clinical, biological and evolutionary profile of AKI due to SM in the pediatric department of Sylvanus Olympio Teaching Hospital of Lome. Our paper discusses the possibility to develop peritoneal dialysis in this country.</p></sec><sec id="s13"><title>Conflicts of Interest</title><p>The authors of this manuscript have no conflicts of interest to disclose as described by the OJNEPH.</p></sec><sec id="s14"><title>Cite this paper</title><p>Sabi, K.A., Kaza, B.N.K., Amekoudi, E.Y.M., Tia, W.M., Vigan, J., Ibrahim, H., Mahamat, G.A., Amouzou-Glikpa, S. and Djadou, E. (2018) Acute Kidney Injury during Malaria in Togolese Children. Open Journal of Nephrology, 8, 85-93. https://doi.org/10.4236/ojneph.2018.84010</p></sec><sec id="s15"><title>Abreviations</title><p>AKI: Acute Kidney Injury; SM: Severe Malaria; RIFLE: Risk Injury Failure Loss End stage.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.88437-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yakpa, W.F. (2012) Malaria and Pregnancy in Togo. http://ao.um5s.ac.ma/xmlui/handle/123456789/1827</mixed-citation></ref><ref id="scirp.88437-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Conroy, A.L., Hawkes, M., Robyn, E., Elphinstone, Morgan, C., Hermann, L., Barker, K.R., Namasopo, S., et al. (2016) Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated with Increased Mortality. Open Forum Infectious Diseases, 3, ofw046. https://doi.org/10.1093/ofid/ofw046</mixed-citation></ref><ref id="scirp.88437-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Nguansangiam, S., Day, N.P., Hien, T.T., et al. (2007) A Quantitative Ultrastructural Study of Renal Pathology in Fatal Plasmodium falciparum Malaria. Tropical Medicine &amp; International Health, 12, 1037-1050. https://doi.org/10.1111/j.1365-3156.2007.01881.x</mixed-citation></ref><ref id="scirp.88437-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kapoor, K. and Gupta, S. (2012) Malarial Acute Kidney Injury in a Paediatric Intensive Care Unit. Tropical Doctor, 42, 203-205. https://doi.org/10.1258/td.2012.120196</mixed-citation></ref><ref id="scirp.88437-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Imani, P.D., Odiit, A., Hingorani, S.R., et al. (2013) Acute Kidney Injury and Its Association with In-Hospital Mortality among Children with Acute Infections. Pediatric Nephrology, 28, 2199-2206. https://doi.org/10.1007/s00467-013-2544-2</mixed-citation></ref><ref id="scirp.88437-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Zaki, S.A., Shenoy, P., Shanbag, P., et al. (2013) Acute Renal Failure Associated with Malaria in Children. Saudi Journal of Kidney Diseases and Transplantation, 24, 303-308. https://doi.org/10.4103/1319-2442.109585</mixed-citation></ref><ref id="scirp.88437-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kunuanunua, T.S., Nsibu, C.N., Gini-Ehungu, J.L., et al. (2013) Acute Renal Failure and Severe Malaria in Congolese Children Living in Kinshasa, Democratic Republic of Congo. Néphrologie &amp; Thérapeutique, 9, 160-165. https://doi.org/10.1016/j.nephro.2013.01.001</mixed-citation></ref><ref id="scirp.88437-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Assimadi, J.K., Gbadoé, A.D., Atakouma, D.Y., Agbénowossi, K., Lawson-Evi, K., Gayibor, A. and Kassankogno (1998) [Severe Malaria in Children in Togo]. Archives de Pediatrie, 5, 1310-1315. https://doi.org/10.1016/S0929-693X(99)80048-7</mixed-citation></ref><ref id="scirp.88437-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Akcan-Arikan, A., Zappitelli, M., Loftis, L.L.,Washburn, K.K., Jefferson, L.S. and Goldstein, S.L. (2007) Modified RIFLE Criteria in Critically Ill Children with Acute Kidney Injury. Kidney International, 71, 1028-1035. https://doi.org/10.1038/sj.ki.5002231</mixed-citation></ref><ref id="scirp.88437-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Olowu, W.A. and Adelusola, K.A. (2004) Pediatric Acute Renal Failure in Southwestern Nigeria. Kidney International, 66, 1541-1548. https://doi.org/10.1111/j.1523-1755.2004.00918.x</mixed-citation></ref><ref id="scirp.88437-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kochar, D.K., Gajanand, S.T., Poonam, C.K., Sanjay, K.K., Ghanshyam, S.S., Anjana, G. and Abhishek, K. (2010) Clinical Features of Children Hospitalized with Malaria: A Study from Bikaner, Northwest India. The American Journal of Tropical Medicine and Hygiene, 83, 981-989. https://doi.org/10.4269/ajtmh.2010.09-0633</mixed-citation></ref><ref id="scirp.88437-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Erunkulu, O.A., Hill, A.V., Kwiatkowski, D.P., Todd, J.E., Iqbal, J., Berzins, K., Riley, M. and Greenwood, B.M. (1992) Severe Malaria in Gambian Children Is Not Due to Lack of Previous Exposure to Malaria. Clinical and Experimental Immunology, 89, 296-300. https://doi.org/10.1111/j.1365-2249.1992.tb06948.x</mixed-citation></ref><ref id="scirp.88437-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gbadoé, A.D., Kini-Caussi, M., Koffi, S., Traoré, H., Atakouma, D.Y., Tatagan-Agbi, K. and Assimadi, K.J. (2006) [Evolution of Severe Pediatric Malaria in Togo between 2000 and 2002]. Medicine et Maladies Infectieuses, 36, 52-54. https://doi.org/10.1016/j.medmal.2005.10.006</mixed-citation></ref><ref id="scirp.88437-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Daubrey-Potey, T.H., Die-Kacou, H., Kamagate, M., Vamy, M., Balayssac, E. and Yavo, J.C. (1990) [Blackwater Fever during Antimalarial Treatment in Abidjan (West Africa): Report of 41 Cases]. Bulletin de laSociete de PathologieExotique, 97, 325-328.</mixed-citation></ref><ref id="scirp.88437-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Bodi, J.M.., Nsibu, C.N., Aloni, M.N., Lukute, G.N., Kunuanuna, T.S,. Tshibassu, P.M. and Pakasa, N. (2014) Black Water Fever Associated with Acute Renal Failure among Congolese Children in Kinshasa. Saudi Journal of Kidney Diseases and Transplantation, 25, 1352-1358. https://doi.org/10.4103/1319-2442.144326</mixed-citation></ref><ref id="scirp.88437-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Aloni, M.N., Celestin, N.N., Meeko-Mimaniye, M., Ekulu, P.M., et al. (2012) Acute Renal Failure in Congolese Children: A Tertiary Institution Experience. Acta Paediatrica, 101, e514-e518. https://doi.org/10.1111/j.1651-2227.2012.02827.x</mixed-citation></ref><ref id="scirp.88437-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Djadou, K.E., Komlangan, A., Balaka, B., Dokounor, D., Gbadoe, A.D., Atakouma, D., Agbere, A.D., Kessie, K. and Assimadi, K. (2006) Management of Severe Malaria in Children at Tsévié Regional Hospital Center (Togo). Archives de pédiatrie, 13, 1555-1556. https://doi.org/10.1016/j.arcped.2006.09.010</mixed-citation></ref><ref id="scirp.88437-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Al-Mendalawi, M.D. (2013) Acute Renal Failure Associated with Malaria in Children. Saudi Journal of Kidney Diseases and Transplantation, 24, 1255. https://doi.org/10.4103/1319-2442.121298</mixed-citation></ref><ref id="scirp.88437-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sabi, K.A., Noto-Kadou-Kaza, B., Amekoudi, Y.E., Tsevi, M.C., Kossidze, K. and Amedegnato, D. (2014) [Epidemiologic and Clinical Profile of Patients at Their First Consultation with a Nephrologist in Togo]. Médecine et Santé Tropicales, 24, 169-171.</mixed-citation></ref><ref id="scirp.88437-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Naqvi, R., Ejaz, A., Fazal, A., Anwar, N. and Adib, R. (2003) Outcome in Severe Acute Renal Failure Associated with Malaria. Nephrology Dialysis Transplantation, 18, 1820-1823. https://doi.org/10.1093/ndt/gfg260</mixed-citation></ref></ref-list></back></article>